. However, why some heavily exposed individuals never acquire, or perhaps immediately eliminate, infection is poorly understood.
No reliable test exists that directly detects the presence or absence of M. tuberculosis in asymptomatic individu als. The purified protein derivative (PPD) skin reactivity test measures delayed type hypersensitivity to mycobac terial antigens and has been the gold standard for the diagnosis of LTBI for >100 years 9, 10 . As PPD is enriched for protein antigens 11 that are not necessarily specific to M. tuberculosis, prior immunization with Mycobacterium bovis Bacillus Calmette-Guérin (BCG) or exposure to non tuberculous mycobacteria can yield false positive results. IFNγ release assays (IGRAs) were developed as a whole blood diagnostic test that measures IFNγ release from M. tuberculosis antigenspecific CD4 + T cells after stimulation with two to three specific M. tuberculosis antigens and thus avoids false positive results from prior BCG vaccination 8 . In the absence of a direct measure of infection, the best surrogates for initial infection are the PPD skin reactivity test and/or IGRA responses that convert from negative to positive (that is, incident positive) after M. tuberculosis exposure.
In endemic TB settings, some adults who are heavily and repeatedly exposed to M. tuberculosis remain neg ative for reactivity in the PPD test and the IGRA. These individuals, whom we term resisters, can be defined clin ically as resistant to infection (FIG. 1) . However, as this designation includes several assumptions about expo sure and the stability of the results of these diagnostic tests, we propose the following enrolment criteria for studies of resisters (Box 1). First, a high level of exposure is crucial and should include indices of exposure inten sity (for example, high bacillary load of a known index case and close proximity of contact, such as sharing a room or bed) as well as indices of exposure duration that capture cumulative exposure (for example, repeated household exposures or employment in settings of docu mented high M. tuberculosis transmission), all of which can be assessed using validated exposure risk scores 12, 13 . Second, diagnosis of a resister requires a negative result for both the PPD skin reactivity test and the IGRA to avoid misclassification. Third, these diagnostic tests should be carried out serially following documented exposures to capture any conversions to LTBI (or TB).
Purified protein derivative (PPD) skin reactivity test
A delayed-type hypersensitivity test that measures induration at the site of an intradermal injection of peptide extract from mycobacterial culture filtrate. A positive result reflects a prespecified minimal diameter of skin induration and suggests the presence of latent Mycobacterium tuberculosis infection but may also result from non-M. tuberculosis sensitization, including prior vaccination with Mycobacterium bovis Bacillus Calmette-Guérin. Also known as the Mantoux tuberculin skin test (TST).
Bacillus Calmette-Guérin (BCG) . A culture-adapted, attenuated Mycobacterium bovis strain that is used for vaccination against Mycobacterium tuberculosis. The resister phenotype is probably heterogeneous and might involve innate immunological mechanisms of early clearance of M. tuberculosis (innate resisters). Alternatively, protective immunity might also occur through adaptive immune responses (adaptive resisters), including IFNγ independent responses that have been measured in preclinical models [14] [15] [16] , and thus a poten tial role for B cell or unconventional T cell responses in early clearance of M. tuberculosis should be consid ered. Longitudinal, rigorous epidemiological studies of resisters, together with data from genetic and immunolo gical platforms, are providing new insights into human resistance to M. tuberculosis infection.
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection
In this Review, we describe the epidemiology of the resister phenotype and discuss several caveats about the definition of a resister. Next, we review the genetic deter minants of the resister phenotype and discuss potential effector mechanisms in macrophages, unconventional T cells and B cells. We examine immune factors that pre vent or limit M. tuberculosis infection in innate resisters or adaptive resisters, which could be harnessed for the development of host directed therapies or more effective vaccines and adjuvants.
Epidemiology
Despite the absence of a direct microbiological meas ure of M. tuberculosis in latent infection, historical and rigorous modern epidemiological studies suggest that resisters exist, although their estimated frequency varies in different studies.
Historical case-contact studies. Strong epidemiologi cal evidence suggests that some individuals are natu rally resistant to infection, even after heavy exposure to M. tuberculosis in closed environments. In 1966, all enlisted personnel and officers aboard the destroyer U.S.S. Richard E. Byrd were enrolled in a study after a 5 cm pulmonary cavity was detected (by radiography) in a crew member who suffered progressive respiratory symptoms for the prior 6 months aboard the ship 17 . Of the 308 at risk enlisted crew members, 7 developed active TB, 6 of whom shared the same berthing com partment as the index case. Most crew members in this 'high burden' compartment showed evidence of new infection (either active TB or an incident positive PPD), whereas seven crew members (~10%) were negative for the PPD skin test during the initial study and remained so at follow up. Other studies, including an evaluation of nursing students in the pre antibiotic era, also showed evi dence of PPD negative responses despite intense expos ure to patients with TB (TABle 1) . A systematic review of household contact studies detected heterogeneity in resistance to infection, with an average of 50% of close contacts remaining uninfected 18 . However, these studies reveal substantial variability in PPD conversion rates, which is consistent with unmeasured exposure variables. Individuals who resist infection despite heavy exposure to M. tuberculosis are more likely to have immunogenetic mechanisms of resistance than those who resist infection after a lower extent of exposure. Individuals with resistance to M. tuberculosis infection after intense exposure are termed 'resisters' (white), whereas individuals who test positive in the purified protein derivative (PPD) skin reactivity test and/or the IFNγ release assay (IGRA) can either be asymptomatic (latent M. tuberculosis infection (LTBI); pink) or be symptomatic with tuberculosis (TB; red). DC, dendritic cell.
IFNγ release assays
(IGRAs). Whole-blood immune assays in which a patient's blood is cultured in the presence of select antigens specific to Mycobacterium tuberculosis and the secretion of IFNγ is quantified. Positive results are independent of prior Bacillus Calmette-Guérin vaccination and negative results ensure a sufficient response to a mitogen positive control.
Resister
An individual who remains negative for the purified protein derivative skin reactivity test and the IFNγ release assay throughout serial testing despite heavy exposure to Mycobacterium tuberculosis.
Not surprisingly, proximity and duration of contact with the index case as well as the infectivity of the index case (that is, bacillary burden) were predictors of PPD conversion.
The results of most early studies in hyperendemic conditions suggest that a minority of the population (5-50%) has the resister phenotype, and this variability probably reflects exposure intensity and the duration of follow up 17, 19, 20 . However, the results of some studies sug gest that rates of resistance are higher (for example, up to 70% of exposed individuals are resisters), even after periods of high exposure (that is, sleeping in the same bed or room) to the index case [21] [22] [23] [24] . Importantly, most of these studies either had a short duration of follow up or contained data that were difficult to accurately review by modern epidemiological standards. Finally, the strain of M. tuberculosis probably differed among the various studies and thus might affect transmission rates. For example, increased virulence and transmission might be one of several factors that are involved in the increased range and incidence of the lineage 2/Beijing strains of M. tuberculosis [25] [26] [27] . The results of these early studies suggest that a resister phenotype exists, but the epidemiological methods that were used could not ensure high exposure and adequate follow up to confirm the presence of clinical resistance to M. tuberculosis infection. . If an individual was negative in the PPD skin reactivity test at baseline ( <10 mm induration for HIV negative individuals >5 years old, <5 mm induration for HIVnegative indivi duals ≤5 years old or <5 mm induration for all HIVpositive individuals), repeated PPD skin tests were carried out at 3, 6, 12 and 24 months after enrolment. Among the entire study cohort, 11.7% of adult close household con tacts remained persistently negative in the PPD skin test throughout the two year follow up 12, 36 . Both the South African and Ugandan cohorts described here provide an opportunity to rigorously define the resister phenotype and explore its underlying cellular mechanisms.
Contemporary cohort studies.
Complexities of the resister phenotype. Given that the definition of a resister relies on epidemiological data and utilizes an indirect, immunological measurement of M. tuberculosis infection, it is likely that some resisters are misclassified. Several alternative hypotheses may explain the resister phenotype.
Despite meeting enrolment criteria as a household contact, an individual with a negative result in the PPD skin reactivity test may simply have had insufficient exposure, either from a low intensity of exposure (that is, a low bacillary burden in the index case, minimal contact with the index case or good ventilation within the household) or a short duration of contact with an index case. In the Ugandan study, a published modified epidemiological exposure risk score 13 , consisting of char acteristics of the TB index case and the intensity of the contact with the index case, did not differ between resist ers and individuals with LTBI 12 . This result suggested that all household contacts were highly exposed to M. tuberculosis. Participants in the Ugandan household 
Household contact
An individual who resides within the same domicile as an index case (patient with tuberculosis) for a pre-specified amount of time.
Hyperendemic conditions

Regions in which ongoing
Mycobacterium tuberculosis transmission is unusually high owing to an elevated prevalence of tuberculosis.
Silicosis
An occupational pulmonary disease that is prevalent among gold miners owing to protracted inhalation of silicate dust, which leads to scarring and increased Mycobacterium tuberculosis infection.
Box 1 | Proposed criteria to define the resister phenotype
Resisters (individuals who show resistance to Mycobacterium tuberculosis infection despite long-term, intense exposure to the bacillus) are exemplified by the following characteristics:
Extent of exposure to Mycobacterium tuberculosis • Intensity: high bacillary burden of index case (for example, sputum-positive), closed environment (household, mine shafts and so on) and use of validated epidemiological risk scoring 12, 13 • Duration: cumulative exposures (that is, health-care workers, miners, household contacts or adults with community exposure in hyperendemic areas)
Result of diagnostic tests
• Negative result in both the purified protein derivative (PPD) skin reactivity test and the IFNγ release assay (IGRA)
Durability of responses
• multiple negative results for the PPD skin reactivity test and the IGRA in the first year following exposure • Additional longitudinal testing, when available and if exposures persist, to minimize false negative test results and enrich for conversions after cumulative exposure contact study were re contacted 8-10 years after the original study and were tested multiple times with IGRAs (3 assays over 3 years) and once with a repeat PPD skin reactivity test. Although they were not necessarily re exposed within the same household in the interval since their initial enrolment as a household contact, all these individuals continued to live in areas of Kampala with high TB prevalence in which community exposure to M. tuberculosis might be substantial [37] [38] [39] . These data will further clarify the durability of the resister phenotype.
An alternative explanation for the resister pheno type is that persistently negative results in PPD skin reactivity tests or IGRAs are false negative results owing to the inherent limitations of an immunolog ical definition of a clinical phenotype. Both PPD skin test and IGRA responses are incomplete measures of anti mycobacterial immunity for a number of reasons. As discussed later, these LTBI diagnostic tests fail to detect the response of T cells that are specific for non protein mycobacterial antigens via MHC independent pathways, and IGRAs do not detect the response of antigen specific T cells with alternative (that is, IFNγ independent) cytokine producing profiles [40] [41] [42] . T cell anergy could also cause false negative results in the PPD skin test. In the Uganda study, HIVnegative indi viduals were not more likely to be PPDnegative than HIVpositive individuals, for whom a positive PPD test was defined as induration >5 mm (ReF.
12
). Furthermore, in recent follow up studies, all resisters demonstrated reac tivity to the mitogen positive control that was included in the IGRA methodology (W.H.B. and C.M.S., unpub lished observation), suggesting that generalized CD4 + T cell anergy or depletion alone does not explain the resister phenotype. This does not rule out a contribution of pathogen specific anergy, which has been observed in human lepromatous leprosy 43 .
Resistance to M. tuberculosis probably has a thresh old, above which relative resistance can be overcome by a sufficiently high exposure. For example, in two land mark studies in the 1930s and 1940s in Norway and at the Philadelphia General Hospital, USA, the prevalence of LTBI among nursing students at matriculation was 45.3% (668/1,453) 44 and 57% (366/643) 45 , respectively. At 3year follow up, however, 100% of students that were initially negative for the PPD skin test in both studies converted, and the majority of these negative topositive conversions occurred during the early stages of training. Considering these data, together with those from the contemporary studies discussed earlier, it is possible that repeated testing (for example, serial testing every 4 months with 2 doses 45 ) and the use of tuberculin of non standardized purity (for example, the two early studies were carried out before large scale standardized preparations of tuberculin, such as PPD S, became available in 1941) effectively sensitized some individuals in the absence of natural infection. Non tuberculous mycobacterial infec tions are also known to produce false positive results in the PPD skin test in some populations, a response that could potentially be boosted by serial PPD testing, as was seen with M. tuberculosis infection 46 . Furthermore, the induration thresholds that were used for each method (Mantoux or von Pirquet) were not described in these studies. Nonetheless, the results of these pre antibiotic era studies suggest that absolute M. tuberculosis resistance occurred at a low frequency in these populations.
Relative resistance to M. tuberculosis disease might also be a function of the infectious dose. The classical work of Lange and Chaussé showed that small droplets carrying one bacillus or a few bacilli are the effectors of aerosol transmission and that the vast majority of individuals with TB show only a single Ghon complex 47, 48 . In natural infections, the frequency of exposure to M. tuberculosis is the most parsimonious surrogate for infectious dose, but how consistency of exposure is linked to innate resistance mechanisms is not known. AFB, acid fast bacilli; MDs, medical students; RNs, nursing students; TB, tuberculosis.
a The number of contacts persistently negative for reactivity in the purified protein derivative (PPD) skin test (and the IFNγ release assay , if available) as a proportion of all contacts enrolled in the study (that is, PPD-positive contacts, PPD-negative contacts and PPD converters).
Relative resistance
A threshold phenomenon in which mechanisms of host resistance to Mycobacterium tuberculosis infection may be overcome owing to frequent or lengthy exposure to contacts with a high bacillary burden.
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The epidemiological studies discussed above suggest that some individuals are resistant to M. tuberculosis infection, as defined by a persistently negative result in the PPD skin test and/or the IGRA, despite sustained high level exposures over extended periods of time. Furthermore, these individuals fail to develop active TB over an extended follow up period. Future research to uncover the mechanisms that are involved in resistance to M. tuberculosis infection will require detailed assess ments of exposure to the bacillus to define the resister phenotype (Box 1). The true prevalence of resisters among individuals who have been exposed to M. tuberculosis is not known, but evidence from studies that assessed exposure variables and included longitudinal sampling suggest that the prevalence is <10%.
Genetics
The cellular mechanisms that mediate M. tuberculosis resistance are unknown, although multiple susceptibility loci have been linked to or associated with the resister phenotype in genome wide analyses.
Genetic basis of resistance to other pathogens. Genetic studies indicate that polymorphisms and mutations exist that are associated with resistance to some infections. For example, a 32 bp deletion in CC-chemokine receptor 5 (CCR5) in CD4 + T cells results in relative resistance to infection with R5tropic HIV1 and delays disease progression 49 . Similarly, mutations in the gene encod ing fucosyltransferase 2 (FUT2), which is required for the cell surface expression of histo blood group anti gens (HBGAs; the receptors for norovirus), results in decreased HBGA levels on mucosal surfaces and thus prevents virus uptake and entry into epithelial cells. Consequently, individuals with these FUT2 mutations are completely (100% penetrant) resistant to Norwalk and other norovirus genogroups 50, 51 . Atypical chemokine receptor 1 (ACKR1; also known as DARC and CD234) is the receptor on erythrocytes for Plasmodium vivax. Most west African individuals are homozygous for a promoter mutation that ablates ACKR1 expression in erythrocytes and, consequently, are resistant to P. vivax infection 52 . Although these examples show Mendelian inheritance (for example, single geneinactivating mutations that result in highly penetrant resistance), it is likely that complex polygenic inheritance patterns are important for resistance to other pathogens, including M. tuberculosis.
Genetic studies of purified protein derivative skin reactivity. Numerous lines of evidence, including results from twin 53, 54 , Mendelian primary immunodeficiency 55 , genome wide linkage [56] [57] [58] and candidate gene studies 59, 60 , suggest that host genetics influences susceptibility to TB. Mendelian Susceptibility to Mycobacterial Disease (MSMD) is an immunodeficiency disorder in young children who are susceptible to disseminated BCG and non tuberculous mycobacteria and who have mutations in the IFNγ and IL12 signalling pathways 55 . Several studies also suggest that host genetic factors modulate resistance to M. tuberculosis infection. For example, the intensity of tuberculin reactivity after exposure to household contacts is correlated among siblings but not among unrelated children of the same household 61 . In a genome wide linkage analysis of the Ugandan cohort, suggestive evidence for a linkage of regions on chromosome 2q21-2q24 and chromosome 5p13-5q22 to the resister phenotype was detected 57 . These regions are distinct from the regions that are linked to protection from TB, suggesting that the genetic underpinnings of these two ends of the TB spectrum (that is, asympto matic infection and clinical disease) are unique. In a low endemicity setting, a candidate gene association study of individuals with or without LTBI who had close contact with an index pulmonary TB case reported that poly morphisms in Toll interacting protein (TOLLIP) and Unc51like kinase 1 (ULK1) were associated with LTBI susceptibility 62, 63 . The specific roles of these proteins in the resister phenotype are discussed later.
Another genome wide analysis assessed PPD skin test reactivity in M. tuberculosis exposed South African individuals. This cross sectional study measured rates of PPD positivity both as a binary trait (that is, PPD = 0 mm versus >0 mm) and as a quantitative trait by measure ment of skin induration (in millimetres) 64 . As a binary trait, a significant linkage signal that met the stringent genome wide linkage cut off was found at the TST1 locus on chromosome 11p14. Strikingly, in a later study of the same families, the TST1 locus was found to be genetically indistinguishable (at a resolution of 2-14 Mb) from a major quantitative trait locus (QTL) that controls tumour necrosis factor (TNF) production following stimulation of whole blood with either BCG alone or BCG plus IFNγ 65 . These findings indicate that a genetic determinant linked to TNF secretion in response to BCG and IFNγ might also determine PPD negativity, perhaps through TNF induced microbicidal pathways. However, the genomic resolution around the TST1 locus in these studies was low (2-14 Mb), and this locus includes other genes besides TNF. When reactivity in the PPD skin test was measured in the same study as a quantitative trait (that is, the size of skin induration in millimetres), sig nificant linkage was found with a second locus, TST2, on chromosome 5p15 (ReF.
64
). This region of chromosome 5 overlaps with the region that was associated with the resister phenotype in the Ugandan cohort 57 . Although the TST1 locus was strictly linked to resistance to M. tuberculosis infection and invokes mechanisms that precede T cell priming, the TST2 locus might modulate T cell responses that govern the intensity of the response in the PPD skin test.
HIV infected resisters, who have an increased likeli hood of having inadequate adaptive immune responses owing to CD4 + T cell depletion, might be particularly dependent on innate immune mechanisms for resistance to M. tuberculosis. As HIV and TB are co prevalent in Uganda and Tanzania, this hypothesis was tested in a genome wide association study of PPD reactivity in HIV infected individuals, which found that a locus on chromosome 5q31.1 was significantly associated with both binary (positive or negative in the PPD skin test; P = 1.22 × 10 -8 ) and quantitative (induration in milli metres; P = 1. 45 × 10 -8 ) responses in the PPD skin test 66 . This region contains four genes, including the gene
Ghon complex
The focus of primary Mycobacterium tuberculosis infection in the lung parenchyma that histologically corresponds to a granuloma and radiographically is recognized by its associated lymphadenopathy and calcification.
Quantitative trait locus (QTl). A genomic region containing polymorphisms that are associated with a quantifiable phenotype, such as the extent of induration (in millimetres) in the purified protein derivative skin reactivity test. When variation at these loci affect the expression levels of specific genes, they are referred to as expression QTls.
encoding IL9, which is expressed and secreted by mast cells and T helper 2 (T H 2) cells and was previously associ ated with bronchial hyper responsiveness. Interestingly, an inverse relationship between the incidence of asthma and TB was reported 67, 68 , suggesting that IL9 and its pleiotropic effects on lung inflammatory responses pro tect against M. tuberculosis infection. Although IL9 is an intriguing possible resistance gene, the other genes in the 5q31.1 region may also have a role in resistance to M. tuberculosis. The study also replicated associations in the regions previously identified in HIV negative resist ers (on chromosomes 2, 5 and 11; discussed previously), including susceptibility loci near TST1.
Together, these results suggest that the resister phe notype has polygenic variance; that is, many individual genetic variants each with small individual effects con tribute additively to the phenotype. Although evidence to support broad epistatic effects on infectious disease susceptibility is lacking, gene pair interactions have been described in genome wide analyses of susceptibility to TB 69, 70 and leprosy 71 . Nonetheless, the substantial overlap in the loci that are associated with the resister pheno type or in the results of PPD skin reactivity tests that was detected in independent analyses argues that evolution ary pressure has selected variants that protect against the initial M. tuberculosis infection, at least in geographical regions that are hyperendemic for TB.
Macrophage-mediated resistance
After inhalation, aerosolized M. tuberculosis must navigate multiple intrinsic barriers in the upper air ways, including airway mucins and ciliated epithelial cells. The bacterium then encounters resident alveo lar macrophages, which exhibit pro inflammatory and anti inflammatory responses and are uniquely posi tioned to have a key role in mediating early clearance of M. tuberculosis [72] [73] [74] . The effector functions of alveolar mac rophages might be modulated by neutrophils through, for example, their formation of neutrophil extracellular traps; however, the role of neutrophils in both microbicidal and immunopathological activities is complex and is reviewed elsewhere 75, 76 . M. tuberculosis is recognized by multiple pattern recognition receptors (PRRs) at the cell surface or within the phagosome or by cytosolic PRRs after phago somal rupture 77, 78 . Subsequently, the outcome of infection depends on effective phagosome acidification, phago some-lysosome fusion, 6 kDa early secretory antigenic target (ESAT6) secretion system 1 (ESX1)dependent escape of M. tuberculosis from the phagosome 79 , activa tion of the inflammasome (resulting in maturation of pro IL1β and pro IL18) 78 , upregulation of host genes that are either required for intracellular killing mecha nisms (for example, reactive oxygen species, nitric oxide (produced by inducible nitric oxide synthase), cathelici din antimicrobial peptide (CAMP) 80 and autophagy) or detrimental to the host (that is, IFNβ production follow ing intracellular sensing of M. tuberculosis DNA by cyclic GMP-AMP synthase (cGAS) 81, 82 ) and, ultimately, the acti vation of host cell death pathways (for example, pyropto sis, apoptosis and necroptosis) 83, 84 . Resistance alleles could modu late a number of these airway clearance functions or macrophage antimicrobial mechanisms (FIG. 2) .
Inflammatory signalling pathways. Genetic regulation of inflammatory pathways is well described [85] [86] [87] [88] , and some studies have associated susceptibility to myco bacterial infections with polymorphisms in Toll like receptor (TLR) pathway components [89] [90] [91] [92] [93] [94] [95] [96] , regulators of TLR function 97, 98 , C type lectin receptors 99 , autophagy proteins 100,101 and other pathways for pro inflammatory cytokine production 102 . However, only some of these studies define functional polymorphisms (that affect TLR expression or signalling, for example), and the identified associations with clinical phenotypes require replication in other populations. Interestingly, patients with Mendelian primary immunodeficiency of myeloid differentiation primary response 88 (MYD88) or IL1 receptor associated kinase 4 (IRAK4), which are cen tral to most TLR signalling pathways, do not develop mycobacterial diseases 103 . Furthermore, few human genetic studies have found an association of resistance to M. tuberculosis infection (as opposed to susceptibility to disease) with polymorphisms in genes involved in any of these cellular pathways. A recently discovered single nucleotide polymorphism (rs5743854) in the promoter of the gene encoding TOLLIP is an expression QTL for which the G/G allele is associated with lower TOLLIP expression in monocytes and with increased risk of LTBI, pulmonary TB and meningeal TB 63 . Although the specific mechanisms through which high TOLLIP expression contributes to M. tuberculosis resistance as well as to protection from disease are not known, the known role of TOLLIP in directing autophagy and its negative regulation of TLR2, TLR4 and IL1 receptor (IL1R) suggest that these pathways are mechanisms of resistance. Although replication of the genetic associa tion findings in independent cohorts is needed, the stud ies discussed above suggest that resistance alleles exist and may be relevant to the resister phenotype.
Autophagy. Autophagy limits intracellular survival of M. tuberculosis and maturation of the mycobacterial phagosome 104, 105 . An in vitro genome wide screen iden tified autophagy factors as the host factors that were most influential in restricting the intracellular growth of M. tuberculosis 106 . The M. tuberculosis ESX1 secre tion system is required for autophagy initiation through cGAS-stimulator of interferon genes (STING)triggered recruitment of microtubule associated proteins 1A/1B light chain 3 (MAP1LC3) to autophagosomes 82, 107, 108 , but ESX1 may also be involved in the impairment of autophagosome maturation 109 . Whether autophagy is involved in host protection versus virulence in the mouse model is controversial. Genetic deletion of the key autophagy factor Atg5 in mice results in more severe disease that correlates with both uncontrolled M. tuberculosis growth and exacerbated lung immunopathol ogy 110 . However, this severe disease was later suggested to result from increased neutrophil recruitment in the autophagy protein 5 (ATG5)deficient animals and not from defective autophagy 111 . Genetic variants within the autophagy pathway have been associated with TB in candidate gene association studies 100, 101 , but whether similar variants control LTBI risk is poorly studied. A recent candidate gene association study found that Mycobacterium tuberculosis infection at multiple points in the infection process, including the initial uptake of bacilli into phagosomes and through any of the possible fates of these phagosomes. These fates include effective (versus delayed) phagosome maturation (resulting in the generation of microbicidal products, such as nitric oxide, reactive oxygen species and cathelicidin), fusion with the lysosome (resulting in degradation of the phagosomal contents), recruitment of autophagy factors (resulting ultimately in autophagosome-lysosome fusion) or phagosomal escape of bacteria into the cytosol. Pro-inflammatory cytokine production may result from Toll-like receptor (TLR) ligation or the recognition of signals following phagosomal rupture, including inflammasome-triggered maturation of pro-IL-1β or pro-IL-18 and recognition of cytosolic M. tuberculosis DNA by cyclic GMP-AMP synthase (cGAS) and the resultant stimulator of interferon genes (STING)-dependent interferon regulatory factor 3 (IRF3)-driven transcriptional response. Vitamin D 3 receptor (VDR)-dependent transcription, which requires prior activation of vitamin D to 1α,25(OH) 2 D 3 through TLR or IFNγ signalling events, results in cathelicidin expression. Genetic and cellular evidence exists for a role for the negative TLR regulator Toll-interacting protein (TOLLIP), the autophagy factor Unc51-like kinase 1 (ULK1) and histone deacetylases (HDACs; which are master transcriptional regulators) in resistance. AIM2, absent in melanoma 2; cGAMP, cyclic GMP-AMP; ESAT6, 6 kDa early secretory antigenic target; mTOR , mechanistic target of rapamycin; MYD88, myeloid differentiation primary response protein MYD88; NF-κB, nuclear factor-κB; NLRP3, NOD-, LRR-and pyrin domain-containing 3; TBK1, TANK-binding kinase 1; TFs, transcription factors; TNF, tumour necrosis factor. two polymorphisms in ULK1, which encodes a compo nent of an upstream protein complex that transduces sig nals to central autophagy effectors, were associated with LTBI in Asian contacts of index cases 62 . After adjustment for clinical risk factors for LTBI, each of these ULK1 minor alleles was estimated to confer an 80% reduction in LTBI risk. This result might be due to an improvement in selective autophagy, decreased M. tuberculosis repli cation or increased TNF secretion in response to TLR ligands, as suggested from mechanistic studies using ULK1deficient cells 62 .
Monocyte gene expression and histone deacetylase pathways. One hypothesis to explain the resistance to M. tuberculosis infection in the Uganda study 12 is that fol lowing infection, the expression profiles of blood mono cytes from individuals with LTBI and resisters are distinct. In a comparative transcriptional profiling study, mono cytes from each clinical group were infected ex vivo with M. tuberculosis 112 , and the microarray data were analysed with Gene Set Enrichment Analysis (GSEA) 113 to iden tify host pathways that are associated with each clini cal phenotype (resister and LTBI) according to curated gene sets from transcriptional databases. The gene set that was most significantly associated with the resister group was from a previous study of sodium butyrate stimulated cells 114 . Sodium butyrate is a short chain fatty acid that inhibits histone deacetylases (HDACs), which modify chromatin and regulate cellular function, including signalling pathways 115, 116 . Interestingly, phenyl butyrate, a class I HDAC inhibitor that is known to synergize with vitamin D to induce CAMP production and inhibit M. tuberculosis growth in macrophages 117 , has been tested as a potential host directed therapy for pulmonary TB 118 . Activated vitamin D (1α,25(OH) 2 D 3 ) binds to the vitamin D 3 receptor (VDR), which trans locates to the nucleus to induce expression of CAMP and drive other host processes, including autophagy and autophagosome-lysosome fusion 80 . CAMP has direct antimicrobial activity against M. tuberculosis in the phagosomal compartment 80 . Together, these data suggest that monocytes from resisters and individuals with LTBI respond differently to ex vivo M. tuberculosis infection. Targeting HDACs with inhibitors might provide a novel therapeutic option for M. tuberculosis infections; however, the specific mechanisms by which HDAC dependent pathways are altered in resisters, and whether epigenetic mechanisms or 'trained immunity' are involved, are unknown.
T cell-mediatedresistance Several lines of evidence from human studies and animal challenge models underscore the importance of T cells in controlling M. tuberculosis infection [119] [120] [121] . HIV infected individuals with low CD4 + T cell counts have increased risk of progressing from LTBI to TB. In addition, patients with MSMD have defects in the IL12-IFNγ pathway and increased susceptibility to disseminated mycobac terial infections 55 . Furthermore, mouse models of acute M. tuberculosis infection have demonstrated the impor tance of IFNγ production in controlling bacterial replica tion and survival 122 . However, the source of IFNγ remains controversial, as its production by CD4 + T cells may be dispensable for control of M. tuberculosis infection in some mouse models [14] [15] [16] , whereas IFNγ production is essential in other mouse models 123 . Furthermore, IFNγproducing CD4 + T cells have not emerged as an immunological cor relate of protection from infection in humans, which sug gests that this profile is important but is not sufficient for protection against M. tuberculosis infection 124, 125 . In indivi duals with LTBI, MHC restricted αβ T cells recognize a broad repertoire of MHC class Irestricted and MHC class II restricted M. tuberculosis peptides and exemplify a classical T H 1 cell like response. Implicit in their definition, resisters lack reactivity in the PPD skin test or secretion of IFNγ by T cells following antigen stimulation, although, hypothetically, these individuals might have IFNγ independent T cell responses that mediate resistance to M. tuberculosis or its clearance.
IFNγ-independentT cellresponses.IFNγ independent T cell responses to mycobacterial antigens have been described (FIG. 3) . For example, Cambodian patients with pulmonary TB who remained anergic to PPD following treatment completion displayed tuberculin antigen specific T cell responses in vitro that were characterized by the production of IL10 rather than IFNγ 126, 127 . IL10, which is known for its anti inflammatory role in mitigat ing T H 1 cell responses to minimize the potentially dele terious effects of TNF and IFNγ, is mostly implicated in the immune response to TB, and no evidence exists for a protective role of IL10 in the early stages of M. tuberculosis infection 128 . However, a genotyping study in Ghana found that individuals with the IL10 promoter haplotype with the highest association with low circulating levels of IL10 were more likely to have TB or be PPD positive than to be PPD negative 129 . Whether high IL10 levels in these individuals truly confer resistance to infection, as opposed to PPD specific anergy in the presence of LTBI, remains to be determined.
Additional CD4 + T cell subsets, including T H 17 cells, could contribute to the resister phenotype through IFNγ independent mechanisms. In mice, the produc tion of IL17A, one of several T H 17related cytokines, recruits neutrophils and other inflammatory cells to the lung and is involved in granuloma maturation 130 . Adoptive transfer of BCG specific T H 17 cells har vested from immunized IFNγ deficient mice into recipient V(D)J recombination activating protein (RAG)deficient mice gave these recipient mice a sur vival advantage when challenged with M. tuberculosis, which was comparable to that seen with transfer of T H 1 cells from IFNγ competent mice 131 . This IFNγ independent partial protection provided by T H 17 cells against M. tuberculosis was also seen in another adoptive transfer model 132 . Unlike IL10, IL17 is not known to directly interfere with IFNγ production, and whether these IFNγ independent T H 17 activities are relevant to the resister phenotype is unknown. However, taken together, these examples illustrate that despite having persistent negative responses in PPD skin reactivity tests and IGRAs, it is possible that resisters have other mycobacteria specific MHC class I restricted or MHC class II restricted T cell responses.
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UnconventionalT cellresponses.In addition to myco bacterial protein antigens, T cells also recognize non protein mycobacterial antigens (FIG. 3) . For example, T cells are activated by mycobacterial cell wall lipids that are bound to CD1 proteins, which are homologous to MHC class I molecules but are functionally non polymorphic 40, 133, 134 . The human CD1 locus encodes four proteins (CD1A-CD1D) that are localized at the cell surface and present lipid antigens to T cells. In a cross sectional study of South African adolescents with or without LTBI, there were low intra donor correlations between T cell responses to protein and lipid antigens 135 , indicating that T cell responses to lipid antigens are not redundant with those to protein antigens and that the responses to the different antigens could be comple mentary. Immunity to lipid antigens could be primed by exposure in early life to non tuberculous mycobac teria, which could facilitate clearance of M. tuberculosis following infection, thus limiting the initiation of peptide specific T cell responses that are mostly respon sible for producing a positive result in the PPD skin test. In addition, lipid specific T cells could also be primed by vaccination with BCG. Functionally, T cells specific for mycobacterial lipids have been shown to have a T H 1 cell cytokine producing profile ex vivo, supporting their role in the clearance of M. tuberculosis infected cells 136 . The MHC class I related gene protein (MR1) antigen presenting molecule presents small molecules instead of peptides or lipids to T cells 137 and is important for the development of mucosal associated invariant T (MAIT) cells [138] [139] [140] . MAIT cells can kill M. tuberculosis infected cells in an MR1dependent manner 41 , and Mr1knockout mice have a higher lung burden of M. bovis BCG than wildtype mice 141 . Furthermore, in candidategene association studies, MR1 and CD1 polymorphisms were associated with susceptibility to TB 142, 143 . Finally, γδ T cells are a T cell lineage that express a heterodimeric T cell receptor and are activated by phosphorylated prenyl metabolites 144, 145 . Vγ9Vδ2 T cells are activated by BCG infected cells and can lyse BCG infected target cells 146 . Thus, in PPD negative individuals, the CD1specific, MR1specific and γδ T cell populations might provide cellular immunity against M. tuberculosis that is inde pendent of the IFNγ production by PPD specific CD4 + T cells that defines LTBI. Further study is required to determine whether these other populations of T cells protect against M. tuberculosis infection in resisters or, alternatively, whether these T cells prevent progression of LTBI in individuals who are unable to produce IFNγ in response to M. tuberculosis antigens.
B cell-mediated resistance Antibodies are powerful mediators of protective immu nity against many infectious diseases, and stimulating their production is the goal of vaccination strategies 147, 148 . In M. tuberculosis infection and disease, however, the role of humoral immunity is probably complex and remains unclear 149, 150 . Passive transfer of antibodies has not consistently conferred protection [151] [152] [153] [154] , and immuno globulin G (IgG)deficient individuals do not exhibit reduced control of bacterial infections 155 . By contrast, a post hoc analysis of the MVA85A vaccine trial found that elevated Ag85A specific IgG titres correlated with protection against TB 156 . In addition, depletion of B cells in a non human primate model of M. tuberculosis infection resulted in increased lesional bacterial bur den 157 . Furthermore, in patients with active TB, B cell function is initially abnormal but returns to normal after successful treatment 158, 159 . These observations highlight the immunoregulatory role of B cells in controlling M. tuberculosis infections, which extends beyond their direct antibody mediated effector functions (FIG. 4) .
Antibodies and latent Mycobacterium tuberculosis infection. Antibodies, plasma cells and antibody responsive innate immune cells that express crystallizable fragment (Fc) receptors are abundant in M. tuberculosis granulomas 160, 161 , indicating that these 164 , which is highly expressed by natural killer cells, neutrophils, mature macrophages and dendritic cells 163 . Furthermore, these antibodies not only improved innate immune cell activity but also contributed to the restriction of intracellular survival of M. tuberculosis in previously infected primary macrophages. Interestingly, this differential functional activity was not related to altered subclass selection but was instead related to sub stantial changes in antibody glycosylation among the M. tuberculosis infected individuals 164 .
Antibodies and the resister phenotype. It is unclear whether antibodies contribute to the resister phenotype, but it is plausible that at the time of repeated M. tuberculosis exposure that pre existing antibodies might direct the antimicrobial activity of macrophages, neutrophils or dendritic cells to eliminate the bacteria more effec tively. Although in vitro studies indicate a limited role for antibody mediated opsonophagocytic prevention of macrophage infection by M. tuberculosis, the addition of pooled IgG derived from individuals with LTBI to previ ously infected healthy donor primary macrophages can drive bacterial elimination by a process that probably involves activation of the inflammasome 164 . These results suggest that, in addition to their minor role in limiting initial infection through opsonization, antibodies 'cure' infected macrophages if they are present at the right time and place. Although the majority of healthy donor macro phages restricted M. tuberculosis survival in the presence of pooled IgG from individuals with LTBI 164 , the level of restriction varied by macrophage donor, which suggests that antibodymediated killing of M. tuberculosis is also dependent on factors that are intrinsic to innate immune cells.
Thus, whether natural or affinity matured humoral immunity exists among resisters is unknown, but humoral immunity might provide an exciting novel immunological axis that links the adaptive and innate immune responses to target and eradicate M. tuberculosis after exposure and warrants further exploration.
Conclusions and outlook
Historically, significant breakthroughs in treating infec tious diseases have been made by studying mechanisms of resistance rather than susceptibility to infections. The most notable historical example is the observation that milkmaids exposed to cowpox were resistant to small pox 165 . A more contemporary example is the HIV resist ance of individuals with a variant of CCR5, CCR5Δ32 (ReFS 166, 167 ). Both these observations led to transformative therapeutic interventions -the smallpox vaccine and CCR5 inhibitors, respectively 168 . For much of the past century, many investigators have postulated that some individuals are naturally resistant to M. tuberculosis infection in the face of intense exposure. However, a number of challenges have impeded the elucidation of potential resistance mechanisms, including the limitations of using an indi rect immunological test to define the resister phenotype and the need to incorporate measurements of exposure intensity in study designs. Despite this, contemporary epidemiological evidence supports the existence of resisters. Genome wide association analysis of data from independent studies has identified loci that are associ ated with resistance to M. tuberculosis infection. The elu cidation of immunological and genetic mechanisms of the resister phenotype is at an early stage, but these stud ies might reveal heterogeneous protective responses that are relevant to different types of resisters. For example, macrophage dependent pathways that prevent bacterial uptake or rapidly clear M. tuberculosis before the devel opment of an adaptive immune response define innate resisters. Alternatively, adaptive resisters are individuals in which T cell and B cell effector functions eliminate or restrict M. tuberculosis infections, either independently of IFNγ production or through priming by non protein antigens. Further study is required to clarify whether adaptive resisters have greater resistance to progression to active TB than individuals with traditionally defined LTBI; however, these studies could identify novel cor relates of immune protection or aid current prognostic efforts to stratify those individuals who are most at risk of disease progression 4, 5 . Looking ahead, integrated research approaches using advanced epidemiological, genetic and immunological tools will be required to dissect mechanisms of resist ance. In future studies, features of an optimally defined resister should incorporate several variables outlined in Box 1, including, first, indices of exposure (both intensity and duration) using, at a minimum, validated epidemio logical risk scoring 12, 13 ; second, the use of both the PPD skin reactivity test and the IGRA to avoid misclassifica tion bias resulting from discordant immunological tests; and third, longitudinal sampling for serial LTBI testing.
Epidemiological risk scores must include an assess ment of the nature of contact between the index case or cases and the exposed individual (that is, whether the index case is the primary caregiver and the frequency and proximity of contact) and some assessment of infectivity of the exposure environment (for example, whether the index case is coughing, whether their spu tum is smear positive for M. tuberculosis and whether there are multiple index cases within a household or employment setting).
Although not yet ready for prac tical implementation, more advanced assessments of infectious risk, such as aerobiological environmental sampling where transmission risk has been correlated with the degree of ventilation and with the number of viable bacteria sampled from cough aerosols, could be incorporated in future studies 37, 169, 170 . Even in areas of high TB endemicity, some level of discordance exists between the results of PPD skin reac tivity tests and IGRAs 171 . Consequently, individuals with discordant results in the PPD skin reactivity test and the IGRA are not categorized as resisters, although retaining clinical samples from these individuals is important to facilitate studies to better understand the mechanistic basis of this discordance. As the resister category might encompass multiple biological phenotypes, at this early stage in their characterization, we favour more stringent criteria to avoid misclassification, which justifies the increased expense and logistical complexity of imple menting multiple testing modalities (PPD skin reac tivity tests and IGRAs) and serial testing. Longitudinal sampling should include, at a minimum, multiple LTBI diagnostic tests in the year following initial exposure, as most but not all conversions occur in the first 3 months following exposure 36 . In circumstances in which resist ers remain in regions of high M. tuberculosis transmis sion, follow up testing may be warranted to ensure that any new conversions owing to community exposures are detected.
Advances in the past decade have transformed genetic methods and platforms, which now include affordable and standardized genome wide detection of polymorphisms. These tools provide assessment of polymorphisms that are annotated in public databases. Whole genome sequencing is also more affordable and can be used to examine resisters for unidentified poly morphisms that are not annotated in public databases. To address limitations in the availability of patient samples, new advances in stem cell work (for example, induced pluripotent stem cells derived from peripheral blood mononuclear cells) have made possible the creation of permanent cell lines from individuals, which can be diff erentiated into different cell types that are more relevant for studying M. tuberculosis pathogenesis (for example, alveolar macrophages). Finally, if M. tuberculosis cultures from index cases are available, comparisons of strain type, host phenotype (resister versus LTBI versus TB) and host genotype, as well as determination of whether transmission events are sympatric or allopatric 172 , are exciting avenues of investigation.
The integration of rigorous epidemiological pheno typing with mechanistic studies that investigate global immune pathways in macrophages, T cells and B cells, and how these pathways might differ between resisters and individuals with LTBI, should provide further biological insight into the mechanisms of early clearance or preven tion of infection by M. tuberculosis. These potential bio logical mechanisms should provide targets for drugs and vaccines that could improve specific immune functions and improve therapeutic options for treating TB.
